Abstract: The invention relates to a method for identifying a battery type (Pb, Li ion) by means of a battery testing device (1), having the steps: application of a DC pulse having a current strength (IB) of at least 30. Ampere to a battery (18) to be tested for at least five seconds; before the application of the pulse, measurement of a pre-pulse voltage (U0) of the battery; during the application of the pulse, measurement of a pulse voltage (U1) of the battery; determination of a transition voltage difference between the pre-pulse voltage and the pulse voltage; determination of a characteristic of a transition voltage difference parameter in dependence upon the transition voltage difference; assignment of a specific battery type (Pb, Li ion) to the tested battery in dependence upon the characteristic; and a battery testing device and a battery testing system.

Abstract: The invention relates to a method for identifying a battery type (Pb, Li ion) by means of a battery testing device (1), having the steps: application of a DC pulse having a current strength (IB) of at least 30 Ampere to a battery (18) to be tested for at least five seconds; before the application of the pulse, measurement of a pre-pulse voltage (U0) of the battery; during the application of the pulse, measurement of a pulse voltage (U1) of the battery; determination of a transition voltage difference between the pre-pulse voltage and the pulse voltage; determination of a characteristic of a transition voltage difference parameter in dependence upon the transition voltage difference; assignment of a specific battery type (Pb, Li ion) to the tested battery in dependence upon the characteristic; and a battery testing device and a battery testing system.

Abstract: The invention concerns the use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation selected among the group consisting of alpha-eleostearic acid, catalpic acid, calendic acid, jacaric acid, licanic acid and beta-eleostearic acid for making a medicine for treating inflamatory diseases and/or metabolic disorders following an inflammation. The inflammatory diseases and/or metabolic disorders following an inflammation may be skin cancers, sun burn, benign summer light eruption, allergic and/or irritative reactions, gingivitis and periodontitis, vulvitis and vaginitis or arthritis and arthrosis. The medicine also enables healing to be promoted. Said fatty acid conjugates can also be used in the cosmetic treatment of cellulitis.